Temporal patterns and risk factors of clozapine-associated neutropenia: a nationwide population-based cohort study

Summary: Background: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, but neutropenia concerns continue to limit its use. Large real-world evidence on temporal risk patterns, re-initiation, and patient-level determinants remains limited.